Day: March 16, 2023

Predictive Oncology Announces Distribution of Series F Preferred Stock to Holders of its Common Stock

Predictive Oncology Announces Distribution of Series F Preferred Stock to Holders of its Common Stock

EAGAN, Minn., March 16, 2023 (GLOBE NEWSWIRE) — Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series F Preferred Stock, par value $0.01 per share, for each outstanding share of the Company’s common stock held of record as of 5:00 p.m. Eastern Time on March 27, 2023. The shares of Series F Preferred Stock will be distributed to such recipients at 5:00 p.m. Eastern Time on March 27, 2023. The outstanding shares of Series F Preferred Stock will vote together with the outstanding shares of the Company’s common stock, as a single class, exclusively with respect to a reverse stock split, as well as any proposal to adjourn any meeting of stockholders called for the purpose of voting on...

Continue reading

Atari Announces Acquisition of 12 Classic Arcade Properties, Including Berzerk and Frenzy

Atari Announces Acquisition of 12 Classic Arcade Properties, Including Berzerk and Frenzy

A Dozen Retro Titles Join Atari’s Expansive Library of New and Old Favorites NEW YORK, March 16, 2023 (GLOBE NEWSWIRE) — Atari® — one of the world’s most iconic consumer brands and interactive entertainment producers — announced today the acquisition of a dozen retro arcade games, including the 80s classics Berzerk and Frenzy. Atari will seek to expand digital and physical distribution of the classic titles, create new games based on the IP, and explore brand and merchandising collaborations. Berzerk is a top-down, multidirectional shooter designed by Alan McNeil that was released for arcades in 1980. Frequently ranked in Top 100 Video Game lists, Berzerk is best known as one of the first arcade video games with speech synthesis, and for the iconic villain Evil Otto. In Berzerk, players navigate a maze of rooms while fighting...

Continue reading

HF Foods Reports Fourth Quarter and Full Year 2022 Financial Results

HF Foods Reports Fourth Quarter and Full Year 2022 Financial Results

Full Year Net Revenue up 47% to $1.2 Billion Distribution Network Services Over 15,000 Customers Across 46 States LAS VEGAS, March 16, 2023 (GLOBE NEWSWIRE) — HF Foods Group Inc. (NASDAQ: HFFG), a leading food distributor to Asian restaurants across the United States (“HF Foods”, “HF Group” or the “Company”), reported unaudited financial results for the fourth quarter and full year ended December 31, 2022. On January 31, 2023, HF Foods filed its Annual Report on Form 10-K for the year ended December 31, 2021 and its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2022, June 30, 2022 and September 30, 2022, and regained compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic reports. The Company does not expect to file its Annual Report on Form 10-K for the year ended...

Continue reading

Condor Announces 2022 Year End Results

Condor Announces 2022 Year End Results

CALGARY, Alberta, March 16, 2023 (GLOBE NEWSWIRE) — Condor Energies Inc. is an internationally focused, publicly traded energy company (“Condor” or the “Company”) with activities in the Republic of Kazakhstan (“Kazakhstan”) and the Republic of Turkiye (“Turkiye”), is pleased to announce the release of its audited consolidated financial statements for the year ended December 31, 2022 and 2021 together with the related management’s discussion and analysis. These documents will be made available under Condor’s profile on SEDAR at www.sedar.com and on the Condor website at www.condorenergies.ca. Readers are invited to review the latest corporate presentation available on the Condor website. All financial amounts in this news release are presented in Canadian dollars, unless otherwise stated. Highlights The approvals required to complete...

Continue reading

Cardinal Energy Ltd. Announces Monthly Dividend for March

Cardinal Energy Ltd. Announces Monthly Dividend for March

CALGARY, Alberta, March 16, 2023 (GLOBE NEWSWIRE) — Cardinal Energy Ltd. (“Cardinal” or the “Company“) (TSX: CJ) confirms that our March dividend of $0.06 per common share will be paid on April 14, 2023 to shareholders of record on March 31, 2023. The Board of Directors of Cardinal has declared the dividend payable in cash. This dividend has been designated as an “eligible dividend” for Canadian income tax purposes. About Cardinal Energy Ltd. Cardinal works to continually improve its Environmental, Social and Governance profile and operates its assets in a responsible and environmentally sensitive manner. As part of this mandate, Cardinal injects and conserves more carbon than it directly emits making us one of the few Canadian energy companies to have a negative carbon footprint. Cardinal is...

Continue reading

SmartCentres Declares Distribution for March 2023

SmartCentres Declares Distribution for March 2023

TORONTO, March 16, 2023 (GLOBE NEWSWIRE) — SmartCentres Real Estate Investment Trust (“SmartCentres” or the “Trust”) (TSX:SRU.UN) announced today that the trustees of SmartCentres have declared a distribution for the month of March 2023 of CDN $0.15417 per trust unit, representing CDN $1.85 per unit on an annualized basis. Payment will be made on April 17, 2023 to unitholders of record on March 31, 2023. About SmartCentres SmartCentres Real Estate Investment Trust is one of Canada’s largest fully integrated REITs, with a best-in-class portfolio featuring 185 strategically located properties in communities across the country. SmartCentres has approximately $11.7 billion in assets and owns 34.8 million square feet of income producing value-oriented retail and first-class office space with 98.0% occupancy, on 3,500 acres of owned...

Continue reading

Lifecore Biomedical Signs Term Sheet with Existing Long-Term Customer to Expand CDMO Relationship

Lifecore Biomedical Signs Term Sheet with Existing Long-Term Customer to Expand CDMO Relationship

Provides $10 million upfront cash commitment to Lifecore for infrastructure preparation and production capacity preparation Customer to provide reimbursement for up to $15 million in capital expenditures to expand capacity Contemplates negotiation of multi-year amendment to extend and expand existing relationship CHASKA, Minn., March 16, 2023 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has entered into a term sheet (“Term Sheet”) to seek to expand its existing CDMO relationship with one of its long-term commercial Hyaluronic Acid and CDMO customers, including obtaining certain up-front cash payments and capital reimbursement obligations from the customer and entering into a non-binding agreement...

Continue reading

Adamis Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update

Adamis Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update

Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ET SAN DIEGO, March 16, 2023 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including opioid overdose, allergy, respiratory and inflammatory disease, today announced financial results for the full year ended December 31, 2022, and provided an update on recent corporate developments. General Corporate Highlights Merger Agreement with DMK Pharmaceuticals In October 2022, Adamis announced that it had initiated a process to explore a range of strategic and financing alternatives and had retained an investment bank to assist in evaluating certain alternatives focused on maximizing stockholder value. Potential alternatives to be considered...

Continue reading

Aerojet Rocketdyne Stockholders Approve Proposed Acquisition by L3Harris

Aerojet Rocketdyne Stockholders Approve Proposed Acquisition by L3Harris

EL SEGUNDO, Calif., March 16, 2023 (GLOBE NEWSWIRE) — Aerojet Rocketdyne Holdings, Inc. (NYSE: AJRD) (or the “Company”) announced that at a special meeting held today, its stockholders voted to approve the Company’s proposed acquisition by L3Harris Technologies (NYSE: LHX). 99.7% of votes cast were in favor of the transaction. “We are pleased with the strong support of our stockholders for this transaction with L3Harris,” said Eileen P. Drake, CEO and president of Aerojet Rocketdyne. “Today’s stockholder approval is another milestone in the process of bringing together our two world-class organizations to accelerate innovation and strengthen competition for national security and space exploration propulsion solutions. We remain focused on completing this transaction and delivering the significant expected benefits for our employees,...

Continue reading

Lifecore Biomedical Reports Second Quarter Fiscal Year 2023 Results

Lifecore Biomedical Reports Second Quarter Fiscal Year 2023 Results

Company Announces Intention to Explore Strategic AlternativesSigns Term Sheet with Key Customer to Materially Expand Commercial RelationshipExpands Development Pipeline from 24 to 25 Active Projects as of Fiscal Second Quarter-endSubsequently Transitioned Three Projects to Commercialization with FDA Approval in Fiscal Third Quarter, Expanding Commercial Products from 26 to 29 with 14 CustomersFiscal Second Quarter Earnings Call Scheduled for March 17th, 2023 at 8:30 am Eastern Time CHASKA, Minn., March 16, 2023 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), reported results for the fiscal 2023 second quarter ended November 27, 2022. ANNOUNCEMENT OF INTENTION TO EXPLORE STRATEGIC ALTERNATIVES: Concurrently with the issuance...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.